Wrapping up a fruitful #EANM2025 in Barcelona !

It’s been a real pleasure for MEDraysintell to connect with many experts and partners shaping the future of nuclear medicine and radiopharmaceuticals.
We truly appreciated the insightful discussions around emerging trends, innovation, and strategic developments driving our industry forward.
The MEDraysintell’s team remains committed to providing data-driven market and clinical intelligence that empowers organizations to make informed decisions and achieve sustainable growth.
Didn’t get the chance to meet us at EANM ? Let’s connect ! Our team is always available to discuss 😊